Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 11, 2020 08:18PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
TD AMERITRADE says it is Calgary but will not trade it. My cousin in the states called it to my attention and says Merrill says the same thing. Very confusing but interesting.There is little doubt that is relates to our Zenith IMHO. Carman